UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors

Go back to UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors
Array Biopharma, Inc. (NASDAQ: ARRY) Delayed: 5.35 +0.03 (0.56%)
Previous Close $5.32    52 Week High $7.27 
Open $5.37    52 Week Low $2.39 
Day High $5.53    P/E N/A 
Day Low $5.28    EPS $-0.61 
Volume 4,444,170       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 2,754,171       

NOVARTIS AG (NYSE: NVS) Delayed: 154.61 -2.18 (1.39%)
Previous Close $156.79    52 Week High $89.15 
Open $156.47    52 Week Low $69.84 
Day High $157.34    P/E N/A 
Day Low $154.51    EPS $0.00 
Volume 1,073,158